Anugerah 88 Logo
$18.50+0.01|(+0.05%)
52W H: 21.0152W L: 11.09Beta: 1.21

About Simulations Plus Inc

Frequently Asked Questions

What is the 52-week range for SLP?

The 52-week high is $21.01 and the 52-week low is $11.09.

What is the P/E ratio for SLP?

The Price to Earnings (P/E) ratio is 46.16.

What is the dividend yield for SLP?

The indicated annual dividend yield is 0.61%.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is 6.18%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is 9.88%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 2.29.

Analyst Recommendation Trends

Wall Street analyst consensus for SLP over the last few months:

2026-09-01
Buy: 0
S.Buy: 0
Hold: 7
Sell: 4
2026-08-01
Buy: 0
S.Buy: 0
Hold: 7
Sell: 4
2026-07-01
Buy: 0
S.Buy: 0
Hold: 7
Sell: 4
2026-06-01
Buy: 3
S.Buy: 3
Hold: 5
Sell: 0

Latest SLP News

'HHS launches project to speed up clinical trials' - Axios

https://www.axios.com/2026/09/30/hhs-clinical-trials-redesign

Benzinga9/30/2026

Simulations Plus Expands FDA Adoption of ADMET Predictor® with New Licenses for the Cosmetics Regulatory Science Branch

RESEARCH TRIANGLE PARK, N.C., September 17, 2026--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that the U.S. Food and Drug Administration’s (FDA) Cosmetics Regulatory Science Branch has licensed ADMET Predictor® to support its computational research for modern cosmetic safety assessment. The contract expands the use of Simulations Plus technolog

Yahoo9/17/2026

Simulations Plus Announces The FDA Cosmetics Regulatory Science Branch Has Licensed ADMET Predictor To Support Its Computational Research For Modern Cosmetic Safety Assessment

Agency will use the software platform to support modern cosmetic safety assessment through integrated exposure and toxicity modeling.Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the

Benzinga9/17/2026

Related Stocks (Peers)

Companies operating in similar sectors to SLP:

MDRXCTEVEVHSLPAMWLOPRXDHLFMDHCATVEEV

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-08-03DiBella John Anthony II-1,000$18.28$18,280
2026-07-06DiBella John Anthony II-1,000$18.36$18,360
2026-07-01WOLTOSZ WALTER S-4,177$18.44$77,024
2026-06-16Fiedler-Kelly Jill-7,350--
2026-06-16Fiedler-Kelly Jill-7,350$18.2$133,770
2026-06-16Fiedler-Kelly Jill+7,350$10.05$73,868
2026-06-15Fiedler-Kelly Jill-1,050--
2026-06-15Fiedler-Kelly Jill-1,050$16.51$17,336
2026-06-15Fiedler-Kelly Jill+1,050$10.05$10,553
2026-06-03DiBella John Anthony II-1,000$16.5$16,500
2026-06-01WOLTOSZ WALTER S-15,000$17.43$261,450
2026-05-11Fiedler-Kelly Jill-1,000--
2026-05-11Fiedler-Kelly Jill-1,000$16.53$16,530
2026-05-11Fiedler-Kelly Jill+1,000$10.05$10,050
2026-05-04DiBella John Anthony II-1,000$14.98$14,980
2026-05-04WOLTOSZ WALTER S-15,000$15.13$226,950
2026-05-01Evans Sharlene+2,117--
2026-05-01Paglia John Kenneth+2,117--
2026-05-01WOLTOSZ WALTER S+2,117--
2026-05-01WEINER DANIEL L+2,117--
2026-04-15DiBella John Anthony II-1,000$13.37$13,370
2026-02-06DiBella John Anthony II-10,300--
2026-02-06DiBella John Anthony II+10,300$9.71$100,013
2026-01-30Evans Sharlene+1,776--
2026-01-30Paglia John Kenneth+1,776--
2026-01-30WOLTOSZ WALTER S+1,776--
2026-01-30WEINER DANIEL L+1,776--
2026-01-28Fiedler-Kelly Jill-8,950--
2026-01-28Fiedler-Kelly Jill+8,950$9.71$86,905
2025-12-18WOLTOSZ WALTER S-9,095--
2025-12-01LaVange Lisa-866$16.91$14,644
2025-11-03Evans Sharlene+1,771--
2025-11-03LaVange Lisa+1,771--
2025-11-03Paglia John Kenneth+1,771--
2025-11-03WOLTOSZ WALTER S+1,771--
2025-11-03WEINER DANIEL L+1,771--
2025-10-16Fiedler-Kelly Jill+27,500--
2025-10-16DiBella John Anthony II+27,500--
2025-10-16FREDERICK WILLIAM W+32,500--
2025-10-16OCONNOR SHAWN+50,000--